Immunotherapies: In this episode of Key To My Research, we delve into the groundbreaking work of cancer treatment and especially the field of cancer vaccines. Our guest is Prof. Dr. Juliane Walz. She is a pioneer in peptide-based immunotherapy at the University of Tübingen. From a personal experience with cancer as a teenager, Prof. Dr. Walz has dedicated her life to developing personalized cancer vaccines that harness the body's immune system to fight tumors. Discover how her research is revolutionizing cancer treatment, offering hope where traditional therapies fall short. Learn about the science behind peptide vaccines and the promise they hold for targeting specific cancers.

About Prof. Dr. Juliane Walz: She is professor for Peptide-based Immunotherapy and Medical Director of the Clinical Cooperation Unit Translational Immunology. Her research focuses on the development of novel peptide-based immunotherapeutic concepts for tumor and infectious diseases.

Links:

About Prof. Dr. Walz: https://www.medizin.uni-tuebingen.de/de/das-klinikum/mitarbeiter/profil/1060

Cancer Vaccines: https://www.medizin.uni-tuebingen.de/de/medizinische-fakultaet/forschung/forschungsschwerpunkt-i/impfen-gegen-krebs

Treatment option for tumor patients with the rare DNAJB1-PRKACA gene fusion: https://www.medizin.uni-tuebingen.de/de/das-klinikum/pressemeldungen/meldung/600#

University of Tübingen: https://uni-tuebingen.de/en Excellence Strategy: https://uni-tuebingen.de/en/excellence-strategy

Production: changing time Fotiadis & Veit GbR (https://www.changing-time.de/) , Zentrum für Medienkompetenz (ZFM) (https://uni-tuebingen.de/zfm)

© University of Tübingen, Division II 1 – Research and Excellence Strategy, 2024